Goodwin advised Astex on the agreement. Astex Pharmaceuticals (UK) announced its exclusive worldwide research collaboration and license agreement with MSD to identify small molecule candidates with...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here